Description
Medical need for patients with resistance to covalent Bruton tyrosine kinase inhibitors
Article: Medical need for patients with resistance to covalent Bruton tyrosine kinase inhibitors
€3.03
Related products
-
Article: Highlights in gynaecological cancers
€3.03 Add to cart -
Article: INTRODUCTION
€3.03 Add to cart -
Article: Highlights in respiratory oncology
€3.03 Add to cart -
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€3.03 Add to cart
